Case Review: Chemo Glove Standardisation in BC

No, not every nitrile glove belongs at a chemotherapy administration station. Nitrile describes a material family, not a barrier rating, and the gloves a clinic should treat as chemotherapy barriers are those carrying documented ASTM D6978 permeation testing against the drugs its team actually handles. This case review follows a community oncology clinic in British Columbia where an internal audit caught general-purpose examination gloves mixed into cytotoxic handling, and the nine-week programme the team used to standardise on D6978-tested gloves across four treatment chairs.

Why an Internal Audit Triggered a Glove Review

The clinic runs four treatment chairs, a small compounding room and a supply alcove, preparing and administering chemotherapy on site. Glove purchasing had grown by accretion rather than design: a 4 mil blue nitrile box for examination rooms, a heavier black nitrile box for clean-up, and a bulk case bought during a supply squeeze. Nobody had recorded which glove was meant for which task, because everyone assumed the polymer settled the question.

What the Audit Actually Found

The review found two nitrile SKUs in active circulation. Only one carried documentation of chemotherapy permeation testing; the other met the examination-glove standard governing fit, strength and pinhole limits — a genuine quality benchmark that says nothing about how quickly a cytotoxic drug crosses the film at a molecular level. On the compounding cart the box on the shelf was the untested one, and the documented glove was stored two rooms away. Staff were not ignoring a rule, because no rule had been written: they selected by habit and by whichever box was nearest.

Nitrile Is a Material, Not a Chemotherapy Rating

This is the distinction that most purchasing lists miss. Nitrile examination gloves occupy a well-defined place in medical supply: comfortable, powder-free options with good puncture and chemical resistance for routine clinical contact. ASTM D6319 is the specification that covers those gloves for medical examination use. Chemotherapy resistance sits in a different document entirely: ASTM D6978, the standard hazardous drug programmes cite when they specify a chemotherapy glove.

What ASTM D6978 Measures, and What ASTM D6319 Does Not

ASTM D6978 is a permeation test. It places glove material against a chemotherapy drug preparation and measures how long the drug takes to be detected on the far side of the film — the breakthrough detection time, reported in minutes for each drug tested. The result is a set of drug-specific times, not a single pass or fail grade, so a supplier's report should name the agents you handle. ASTM D6319 does not evaluate chemotherapy permeation at all; it verifies dimensional, physical-strength and watertightness expectations. Reading a D6319 box as though nitrile implied D6978 coverage is the error the audit surfaced.

Thickness and Cuff Length: Support, Not Proof

Film thickness influences how long a drug takes to cross a glove, and heavier nitrile is often reserved for compounding, spill response and cleaning, where fine tactile work matters less — the 6 mil heavy-duty nitrile examination gloves are typically kept for that layer of work. Cuff length matters too: a cuff that sits below a gown cuff leaves a wrist gap. Neither number is a rating: a 6 mil glove with no D6978 report is still an unverified barrier, and a thinner glove with the right documentation answers a different question.

The Standardisation Steps the Clinic Took

The team treated the audit as a standardisation project, not a stocking correction. Three moves did the work.

1. SKU consolidation. Eleven glove line items collapsed to three: one D6978-tested chemotherapy glove, one general examination glove, one heavy-duty glove for clean-up. Fewer options meant fewer chances for the wrong box on the wrong cart.
2. Labeling and placement. The chemotherapy glove was labelled at box level and moved to the compounding room and treatment carts; general examination gloves came out of hazardous drug areas entirely, so the nearest box was also the correct one.
3. Training and change timing. Staff were walked through which glove fitted which task, how to read a D6978 report, and when to change gloves — after a spill, a tear or removal of contaminated outer PPE, and at the interval in the hazardous drug policy.

Training That Stuck: Task, Not Product

The session that changed behaviour was framed around tasks, not products. Compounding, administration, handling drug-contaminated waste and cleaning a spill each got a glove answer, and examination-room contact got a different one. Framed that way, the 4.0 mil powder-free chemo-grade nitrile examination glove became the reference point for cytotoxic tasks — gloves in this class typically carry D6978 documentation and a powder-free construction that removes a separate variable in a clean-handling environment. For the general examination side of that decision, see the powdered vs. powder-free nitrile glove comparison.

General Exam Gloves vs D6978-Tested Chemo Gloves

Results After Two Quarters

Three outcomes held up at the follow-up audit. First, the glove choice matched the task in every observed cytotoxic procedure, and the shelf-position change meant the correct glove was also the nearest one. Second, purchasing simplified: three recurring line items instead of eleven, with the D6978 report filed beside the product specification. Third, glove consumption rose modestly, because double gloving at the chemotherapy station and a defined change interval use more gloves per case than routine examination use ever did. That increase was the cost of the barrier, not waste; wider clinic consumption planning follows our exam room glove consumption benchmark.

What Standardisation Did Not Fix

It is worth being precise about the limits, because a glove programme is one control among several. A tested glove does not replace safe handling technique: the outer glove still has to come off without touching the skin, and doffing is where most self-contamination happens. It does not remove the need for a gown, eye protection or a closed-system transfer device, and it covers only the drugs on the manufacturer's report. Nor does it exempt a clinic from reviewing its policy when drug lists or tasks change. The clinic's summary was blunt: the glove choice is now documented, but documentation is not technique.

How to Copy the Play

1. List every glove SKU in the building and mark which ones carry D6978 data and for which drugs.
2. Write one sentence per task — compounding, administration, spill, waste, examination — naming the glove class that applies.
3. Label at box level and place the chemotherapy glove at the point of use; remove general examination gloves from hazardous drug areas.
4. Set the change interval in the hazardous drug policy and train it as a task rule, not a product fact.
5. File the drug-specific permeation report beside the product specification, dated, so it survives staff turnover.

Warehouse restocking deserves the same rigour: a reorder point that ignores change intervals undershoots demand, the subject of our Winnipeg glove shortage reorder-point case review. The CliniEco learning hub collects the glove and barrier references in one place.

Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.

Related reading

Continue with powdered vs. powder-free nitrile glove comparison, exam room glove consumption benchmark and Winnipeg glove shortage reorder-point case review.

Frequently Asked Questions

Are all nitrile gloves appropriate for chemotherapy administration?

No. Only gloves with documented ASTM D6978 permeation testing for the drugs you handle should be treated as chemotherapy barriers. A nitrile glove meeting ASTM D6319 suits routine clinical contact, but examination-glove testing does not evaluate chemotherapy drug permeation.

What does the ASTM D6978 test actually measure?

It measures permeation — the migration of a chemotherapy drug through intact glove material at a molecular level. Results are reported as a breakthrough detection time in minutes for each drug tested, rather than as a single pass or fail grade.

Is a thicker nitrile glove automatically chemotherapy-rated?

No. Thickness affects how long a drug takes to cross the film, but the rating comes from testing and documentation, not from the millimetre figure on the box. A 6 mil glove with no D6978 results is still an unverified barrier.

How often should chemotherapy gloves be changed?

Change gloves after a known drug contact, after a spill, after removing contaminated outer PPE, and after any tear. The routine interval should follow your facility's hazardous drug policy, which reflects your drug list and the tasks performed.

This article is general information for Canadian clinic supply planning, not clinical or regulatory advice. Confirm glove selection with your facility's hazardous drug handling policy, occupational health requirements, and the manufacturer's instructions for use. CliniEco Medical is a licensed medical device establishment (MDEL #35334).

Auditing your glove supply this quarter? Start by matching the standard to the task, then confirm the D6978 payload rather than the polymer. → Start with a trial: CliniEco 24h Biological Indicator — 5-Pack Trial, and build the chemotherapy glove layer around the 4.0 mil powder-free chemo-grade nitrile examination gloves.

Related Reading

Explore more guides in this category:

• Hospital Gloves and Food Safety in Clinic Kitchens: A Spec Note
• Medical Gloves Per Case in Canada: What Buyers Should Check Before Ordering
• How to Choose Nitrile Gloves for a Canadian Clinic: A Selection Matrix
• RCDSO-compliant sterilization records